Automotive ECU Market Size WorthUSD 45.98 Billion By 2020 :

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jan 19, 2016 at 3:45 AM

Automotive ECU Market Size WorthUSD 45.98 Billion By 2020 : Radiant Insights,Inc

San Francisco, Jan. 19, 2016 (GLOBE NEWSWIRE) -- The global Automotive ECU Market is expected to reach USD 45.98 billion by 2020. Increasing expenditure on R&D in order to lower the ECU costs is expected to propel market growth over the forecast period. Stringent government regulations for advanced safety features, facilitated by low-cost ECU development are expected to fuel automotive ECU market growth. Recent development in ECU technology is oriented towards making devices more sophisticated. Proliferation of in-car infotainment systems in various segments is expected to drive the automotive ECU market through the forecast period.

Continuous growth in the number of embedded components used by automotive manufacturers has spotlighted new opportunities for suppliers. Emergence of V2V and V2I connected systems is expected to spur market growth through the forecast period.

High level of complexity due to integration of automotive domains in order to combine individual ECUs into ECU domains would pose a challenge to market growth. Growing consumer preference towards sophisticated equipment in mid-sized vehicles such as high-end communication & navigation systems is expected to yield opportunities for the automotive electronics market.

Browse Full Research Report With TOC On "Automotive ECU Market Analysis By Application (Powertrain, Chassis Electronics, Safety & Security, Entertainment, Communication & Navigation) And Segment Forecasts To 2020" at: http://www.radiantinsights.com/research/automotive-ecu-market-analysis-by-application-powertrain-chassis-electronics-safety-amp-security-entertainment-communication-amp-navigation-and-segment-forecasts-to-2020

Further key findings from the study suggest:

Safety & security systems segment accounted for the majority of market share in 2013 and is further expected to generate high revenue through the forecast period. Rising safety awareness among consumers is fueling the demand for airbags and anti-lock breaking systems across various vehicle segments.
Communication & navigation systems application segment is expected to witness high demand for automotive ECUs over the forecast period. This can be attributed to advanced features such as in-car data storage, eco-efficiency and sophisticated in-car features. Increasing emphasis on road safety with connected systems is expected to be the key growth driver for the segment.
Asia Pacific is expected to witness high growth due to rising safety installations and increased manufacturing activities. Countries such as China and Japan are expected to favorably impact regional market growth. Newly mandated warning systems for onboard diagnostics systems that help owners to monitor emissions is expected to drive the North America market.
Prominent companies operating in the automotive ECU market include Delphi, Bosch, Continental AG, Denso, TRW Automotive, Autoliv, etc. Key market participants invest heavily in R&D to offer product differentiation as well as cost-effective ECUs by building technology partnerships with other participants in the ecosystem.

Browse All Reports of This Category at: http://www.radiantinsights.com/catalog/automotive

Automotive ECU Application Outlook (Revenue, USD Billion, 2012 - 2020)

Powertrain
Chassis Electronics
Safety & Security
Entertainment
Communication & Navigation

Automotive ECU Regional Outlook (Revenue, USD Billion, 2012 - 2020)

North America
S.
Mexico
Europe
Germany
UK
Asia Pacific
China
India
Japan
RoW
Brazil

Related Reports by Radiant Insights:

Fragrances Market in France –

http://www.radiantinsights.com/research/fragrances-market-in-france-2014-2018

Antibiotics Market –

http://www.radiantinsights.com/research/global-antibiotics-market-2014-2018

About Radiant Insights

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

Contact Details:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519

Email: sales@radiantinsights.com

Web: http://www.radiantinsights.com/

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...